The lawsuit was filed by Larry Gene T., a man from Texas who was implanted with the G2® Express (G2® X) Inferior Vena Cava Filter (“IVC Filter”) manufactured by C.R. Bard Inc. and Bard Peripheral Vascular Inc.
The IVC Filter was surgically implanted on March 26, 2009 at a hospital in Texas. It was implanted in his inferior vena cava, the largest vein in the human body, for the purpose of catching blood clots and preventing a Venous Thromboembolism (VTE).
The plaintiff is a current resident of Texas. He was also a resident of Texas at the time of implant and injury.
The plaintiff is seeking compensation for his injuries and punitive damages against C.R Bard.
The lawsuit accuses C.R. Bard of manufacturing a defective device, failure to warn about side effects, negligent misrepresentation, breach of implied and express warranty, and fraudulent misrepresentation.
The lawsuit was filed on December 29, 2017 in the U.S. District Court for the District of Arizona — Case 2:17-cv-04801-DGC.
It will be centralized with over 4,500 other IVC filter lawsuits that are currently pending against C.R. Bard in a federal Multi-District Litigation (MDL No. 2641) — In Re: Bard IVC Filters Products Liability Litigation.
The plaintiff is represented by Ben C. Martin of The Law Offices of Ben C. Martin in Dallas, Texas. He a trial attorney who serves on the plaintiffs’ steering committee of the Bard IVC Filter MDL.